|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.408 EUR | +0.87% |
|
+3.29% | -11.30% |
| May. 07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
| Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
Gensight Biologics S.A. (ENXTPA:SIGHT) is looking for acquisitions. The company is advancing a number of discussions with potential partners on strategic opportunities, including a merger or acquisition, assessed as one of the relevant options to move forward.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.30% | 34.14M | |
| +7.52% | 111B | |
| +11.38% | 106B | |
| -12.64% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -8.58% | 16.81B | |
| +37.41% | 12.54B | |
| -23.95% | 8.09B |
GENSIGHT BIOLOGICS S.A. 
